FPL 55618

RN given refers to parent cpd

Also Known As:

4H-1-Benzopyran-2-carboxylic acid, 5-(3-methylbutoxy)-4-oxo-8-(2-propenyl)-, sodium salt; 5-(3-methylbutoxy)-4-oxo-8-(2-propenyl)-4H-1-benzopyran-2-carboxylic acid, sodium salt; FPL-55618

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        FPL 55618: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        FPL 55618: 1

Related Diseases

1.	Right Ventricular Hypertrophy 01/15/1981 - "Mast cell stabilizing compound FPL 55618 reduces right ventricular hypertrophy and lung mast cell hyperplasia in chronically hypoxic rats." 01/15/1981 - "Rats treated with chronic hypobaric hypoxia (21 days, 380 Torr) and mast cell stabilizing compound FPL 55618 had significantly less right ventricular hypertrophy and lung mast cell hyperplasia than rats subjected to chronic hypoxia alone. "
2.	Hyperplasia 01/15/1981 - "Mast cell stabilizing compound FPL 55618 reduces right ventricular hypertrophy and lung mast cell hyperplasia in chronically hypoxic rats." 01/15/1981 - "Rats treated with chronic hypobaric hypoxia (21 days, 380 Torr) and mast cell stabilizing compound FPL 55618 had significantly less right ventricular hypertrophy and lung mast cell hyperplasia than rats subjected to chronic hypoxia alone. "
3.	Hypoxia (Hypoxemia) 01/15/1981 - "Rats treated with chronic hypobaric hypoxia (21 days, 380 Torr) and mast cell stabilizing compound FPL 55618 had significantly less right ventricular hypertrophy and lung mast cell hyperplasia than rats subjected to chronic hypoxia alone. "

Related Drugs and Biologics

1.	Mast Cell Stabilizers